Literature DB >> 28185473

Statins for secondary prevention: clinical use in patients with acute coronary syndrome in Wales.

Majd B Protty1, Arron Lacey2, Jamie Hayes3, Phillip Freeman1.   

Abstract

AIM: Statins have a proven role for the secondary prevention of cardiovascular disease. Despite this, typical patient use in real life is variable. Our aim was to investigate the typical clinical use, including adherence, for statins in a sample population in South Wales (UK).
METHODS: We identified 2248 patients admitted to hospitals in South Wales with acute coronary syndrome using a retrospective 3-year-long longitudinal study. We performed data linkage using the Secure Anonymized Information Linkage databank. RESULTS &
CONCLUSION: In total, 1806 (80.3%) of patients were initiated on statins at discharge, with simvastatin being most common. Only 38% of patients were on high-intensity dosage. There was minimal change in cholesterol levels, with discontinuation rates of 53.7 and 84.3% at 1- and 3-year follow-up, respectively.

Entities:  

Keywords:  Wales; cardiovascular disease; secondary prevention; statins

Mesh:

Substances:

Year:  2017        PMID: 28185473     DOI: 10.2217/fca-2016-0060

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  1 in total

1.  Combined treatment with simvastatin and rapamycin attenuates cardiac allograft rejection through the regulation of T helper 17 and regulatory T cells.

Authors:  Yingjie Liu; Lu Sun; Wei Chen; Junbo Chuai; Yu Shang; Dongyang Zhang; Bicheng Fu; Hai Tian; Shulin Jiang
Journal:  Exp Ther Med       Date:  2017-12-14       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.